Nevertheless, the effects of incretin therapy on body composition (e.g. increased relative loss of skeletal muscle [51]) should be investigated in this population, as patients with advanced heart failure often suffer from sarcopenia [52]. The gene discussed is GCG; the disease is sarcopenia.